Trials / Completed
CompletedNCT02675920
A Study of HCC High Risk Group Using Two Surveillance Tools
A Prospective Cohort Study to Compare Contrast Enhanced Liver CT and Ultrasonography for Hepatocellular Carcinoma Surveillance in High-risk Group of HCC: Preliminary Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 139 (actual)
- Sponsor
- Seoul National University Hospital · Academic / Other
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to compare sensitivity for hepatocellular carcinoma (HCC) of bi-annual ultrasonography and low dose computed tomography (LDCT) in patients at high risk of HCC.
Detailed description
Patients at high risk of HCC are recommended to undergo biannual surveillance using ultrasound. In this study, LDCT is performed in addition to biannual ultrasound surveillance in eligible patients to compare their sensitivity for HCC. Standard of reference would be follow-up imaging and/or gadoxetic acid-enhanced liver MRI.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | non-ionic monomer iodinated CT contrast media | patients underwent contrast-enhanced CT using aforementioned CT contrast media (non-ionic monomer iodinated CT contrast media) |
Timeline
- Start date
- 2014-11-28
- Primary completion
- 2019-01-11
- Completion
- 2019-10-01
- First posted
- 2016-02-05
- Last updated
- 2020-10-08
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02675920. Inclusion in this directory is not an endorsement.